Why Verve Therapeutics Stock Is Skyrocketing Today

Shares of Verve Therapeutics (VERV 76.24%) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tuesday. And for good reason. Eli Lilly (LLY -1.40%) and Verve Therapeutics announced a "definitive agreement for Lilly to acquire Verve."Lilly offered $10.50 per share in cash, payable at the closing of the transaction. This represents a premium of around 113% to the 30-day volume-weighted average trading price of Verve stock for the period ending June 16, 2025.In addition, Verve shareholders will receive one n ...